Lv1
40 积分 2024-01-16 加入
P376. Preclinical Pharmacological Characterization of the Selective NR2b Negative Allosteric Modulator BI 1569912 With Potential to Treat MDD
3天前
已完结
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
3天前
已完结
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia
11天前
已完结
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
3个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1年前
已完结
LilrB3 is a putative cell surface receptor of APOE4
1年前
已完结
皖公网安备34019202002308
